Marksans Pharma is engaged in the Business of Formulation of pharmaceutical products.
Financial Results:
Marksans Pharma Ltd reported Revenues for Q4FY24 of ₹560.00 Crores up from ₹486.00 Crore year on year, a rise of 15.23%.
Total Expenses for Q4FY24 of ₹476.00 Crores up from ₹392.00 Crores year on year, a rise of 21.43%.
Consolidated Net Profit of ₹78.00 Crores down 6.02% from ₹83.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹1.73, down 4.42% from ₹1.81 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.